Roberto P. Benzo

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial

Matching patients to clinical trials with large language models

Optimizing the 6-Min Walk Test as a Measure of Exercise Capacity in COPD

The accuracy and efficiency of electronic screening for recruitment into a clinical trial on COPD